Patents by Inventor Scott D. Sorensen

Scott D. Sorensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds
    Patent number: 8410147
    Abstract: This invention is directed to methods of preventing or treating diseases or conditions associated with alterations in cellular integrity including alterations in endothelial permeability, excessive cell proliferation or tissue remodeling. Particularly, this invention is directed to methods of treating diabetic nephropathy, malaria, or cancer. The method comprises identifying a subject in need of the treatment, and administering to the subject an effective amount of a novel rho kinase inhibitor compound to treat the disease.
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: April 2, 2013
    Assignee: Inspire Pharmaceuticals, Inc.
    Inventors: Ward M. Peterson, John W. Lampe, Tomas Navratil, Scott D. Sorensen, Emilee H. Fulcher
  • METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS
    Publication number: 20130005756
    Abstract: This invention is directed to methods of preventing or treating diseases or conditions of the lungs associated with excessive cell proliferation, remodeling, inflammation, vasoconstriction, bronchoconstriction, airway hyperreactivity and edema.
    Type: Application
    Filed: September 12, 2012
    Publication date: January 3, 2013
    Inventors: Tomas NAVRATIL, Ward M. PETERSON, John W. LAMPE, Emilee H. FULCHER, Scott D. SORENSEN
  • Method for treating pulmonary diseases using rho kinase inhibitor compounds
    Patent number: 8299096
    Abstract: This invention is directed to methods of preventing or treating diseases or conditions of the lungs associated with excessive cell proliferation, remodeling, inflammation, vasoconstriction, bronchoconstriction, airway hyperreactivity and edema.
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: October 30, 2012
    Assignee: Inspire Pharmaceuticals, Inc.
    Inventors: Tomas Navratil, Ward M. Peterson, John W. Lampe, Emilee H. Fulcher, Scott D. Sorensen
  • METHOD FOR TREATING CARDIOVASCULAR DISEASES USING RHO KINASE INHIBITOR COMPOUNDS
    Publication number: 20100008968
    Abstract: This invention is directed to methods of preventing or treating diseases or conditions associated with excessive cell proliferation, remodeling, inflammation, and vasoconstriction. Particularly, this invention is directed to methods of treating cardiovascular diseases or conditions such as stent restenosis and thrombosis, vascular thrombosis, cerebral vasospasm, atherosclerosis, systemic hypertension, cardiac hypertrophy, and sexual dysfunction. The method comprises identifying a subject in need of the treatment, and administering to the subject an effective amount of a novel Rho kinase inhibitor compound to treat the disease.
    Type: Application
    Filed: June 26, 2009
    Publication date: January 14, 2010
    Inventors: John W. Lampe, Tomas Navratil, Ward M. Peterson, José L. Boyer, Emilee H. Fulcher, Scott D. Sorensen
  • METHOD FOR TREATING DISEASES ASSOCIATED WITH ALTERATIONS IN CELLULAR INTEGRITY USING RHO KINASE INHIBITOR COMPOUNDS
    Publication number: 20090325905
    Abstract: This invention is directed to methods of preventing or treating diseases or conditions associated with alterations in cellular integrity including alterations in endothelial permeability, excessive cell proliferation or tissue remodeling. Particularly, this invention is directed to methods of treating diabetic nephropathy, malaria, or cancer. The method comprises identifying a subject in need of the treatment, and administering to the subject an effective amount of a novel rho kinase inhibitor compound to treat the disease.
    Type: Application
    Filed: June 26, 2009
    Publication date: December 31, 2009
    Inventors: Ward M. Peterson, John W. Lampe, Tomas Navratil, Scott D. Sorensen, Emilee H. Fulcher
  • METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS
    Publication number: 20090325958
    Abstract: This invention is directed to methods of preventing or treating diseases or conditions of the lungs associated with excessive cell proliferation, remodeling, inflammation, vasoconstriction, bronchoconstriction, airway hyperreactivity and edema.
    Type: Application
    Filed: June 26, 2009
    Publication date: December 31, 2009
    Inventors: Tomas Navratil, Ward M. Peterson, John W. Lampe, Emilee H. Fulcher, Scott D. Sorensen